Evidence map›Paper›PMID 42738137›Full record

ArticleMaterials (Basel, Switzerland)2026

Mechanistic Study on Dual-Donor Modified Distyryl-BODIPY Photosensitizers.

Yunlong Yang, Di Wang, Xue Ma, Jiaye Yang, Guanghui Cheng, Jianfang Cao

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yunlong YangSchool of Chemical Engineering, Ocean and Life Sciences, Panjin Campus, Dalian University of Technology, Panjin 124221, China.
Di WangSchool of Chemical Engineering, Ocean and Life Sciences, Panjin Campus, Dalian University of Technology, Panjin 124221, China.
Xue MaSchool of Chemical Engineering, Ocean and Life Sciences, Panjin Campus, Dalian University of Technology, Panjin 124221, China.
Jiaye YangLeicester International Institute, Panjin Campus, Dalian University of Technology, Panjin 124221, China.
Guanghui ChengDepartment of Energy Chemistry and Materials Engineering, Shanxi Institute of Energy, Jinzhong 030600, China.
Jianfang CaoSchool of Chemical Engineering, Ocean and Life Sciences, Panjin Campus, Dalian University of Technology, Panjin 124221, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work systematically investigates how different electron-donating groups modulate the photophysical properties and singlet-oxygen quantum yields of donor-acceptor (D-A) distyryl boron-dipyrromethene (BODIPY) photosensitizers, with the donors attached at the para positions of both styryl arms. The study focuses on three compounds that have been previously reported in the literature (M1 with a dimethylacridine donor, M2 with a phenoxazine donor, and M3 with a phenothiazine donor), yet only experimental characterizations are available for them. Using computational chemistry methods, we comprehensively analyzed their geometric configurations, spectral features, spin-orbit coupling (SOC) effects, and electron-hole orbital distributions. The calculated results reveal that M2 possesses the lowest oxidation potential and thus the strongest electron-donating ability among the three donors. Compared with M1 and M3, M2 exhibits larger SOC values, a smaller energy gap between the excited singlet and triplet states, and the highest intersystem crossing (ISC) rate constant. Notably, the energy gaps ΔE (T

Indexed as

charge transferdistyryl-BODIPYheavy-atom-freeintersystem crossingphotodynamic therapy (PDT)photosensitizers

Identifiers

PMID42738137
PMCPMC13567294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.